Article
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals
2024-02-09
Abstract excerpt
<h4>SUMMARY</h4> Immunization with mosaic-8b [60-mer nanoparticles presenting 8 SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs)] elicits more broadly cross-reactive antibodies than homotypic SARS-CoV-2 RBD-only nanoparticles and protects against sarbecoviruses. To investigate original antigenic sin (OAS) effects on mosaic-8b efficacy, we evaluated effects of prior COVID-19 vaccinations in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 023a1e13-88eb-5b58-9e23-33110513bd1f
- DOI
- 10.1101/2024.02.08.576722
